Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics

Philip D. Home (Lead / Corresponding author), Rory J. McCrimmon, Julio Rosenstock, Matthias Blüher, Katrin Pegelow, Lydie Melas-Melt, Khier Djaballah, Francesco Giorgino,

    Research output: Contribution to journalArticlepeer-review

    5 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Findings for iGlarLixi versus BIAsp 30 confirmed in groups of people with type 2 diabetes with different biomedical characteristics'. Together they form a unique fingerprint.

    Medicine & Life Sciences